Multimodal Monitoring in Patients With Spontaneous Intracerebral Hemorrhage

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

8 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-12-31

Study Completion Date

2016-06-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Spontaneous intracerebral bleeding also known as spontaneous intracerebral hemorrhage (sICH) constitute 10-15 % of all apoplexies. The Prognosis is considerably worse than it is for the larger population of patients suffering from cerebral thrombosis. Development of brain edema seemingly contributes to the disadvantageous prognosis. However, the mechanisms behind is only understood fragmentarily.

By using multimodal neuro monitoring, the investigators seek to investigate electrophysiological and metabolic processes, which seem to accompany the formation of edema and clinical deterioration in patients suffering from sICH.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cerebrospinal Fluid Hemoglobin to Monitor for Aneurysmal Subarachnoid Hemorrhage Related Secondary Brain Injury

NCT04998370

Subarachnoid Hemorrhage, Aneurysmal Vasospasm Delayed Cerebral Ischemia +1 more

COMPLETED

Monitoring of Delayed Ischemia After Subarachnoid Hemorrhage

NCT01406457

Subarachnoid Hemorrhage

COMPLETED

Improving Outcomes for Patients With Life-Threatening Neurologic Illness

NCT04189471

Intracerebral Hemorrhage Subarachnoid Hemorrhage Intraventricular Hemorrhage +2 more

RECRUITING

Decompressive Hemicraniectomy in Intracerebral Hemorrhage

NCT02258919

Cerebral Hemorrhage

COMPLETED NA

Study of Antithrombotic Treatment After IntraCerebral Haemorrhage

NCT03186729

Cerebral Hemorrhage Intracranial Hemorrhages Atrial Fibrillation +2 more

TERMINATED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Hemorrhage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

spontaneous intracerebral hemorrhage

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis: spontaneous intracerebral hemorrhage verified by CT
* Clinical indication for craniotomy or craniectomy
* Admitted to the hospital within 24 hours from assumed ictus
* Age over 18 years